Fresenius Medical Care AG (FMS)
21.12
+0.08
(+0.40%)
USD |
NYSE |
May 01, 14:13
Fresenius Medical Care Free Cash Flow: 2.105B for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | 2.105B |
| September 30, 2023 | 2.048B |
| June 30, 2023 | 1.838B |
| March 31, 2023 | 1.527B |
| December 31, 2022 | 1.522B |
| September 30, 2022 | 1.563B |
| June 30, 2022 | 1.662B |
| March 31, 2022 | 1.903B |
| December 31, 2021 | 1.935B |
| September 30, 2021 | 1.691B |
| June 30, 2021 | 1.872B |
| March 31, 2021 | 3.328B |
| December 31, 2020 | 3.633B |
| September 30, 2020 | 3.888B |
| June 30, 2020 | 3.777B |
| March 31, 2020 | 2.090B |
| December 31, 2019 | 1.614B |
| September 30, 2019 | 1.572B |
| June 30, 2019 | 1.497B |
| March 31, 2019 | 1.371B |
| December 31, 2018 | 1.186B |
| September 30, 2018 | 935.20M |
| June 30, 2018 | 872.35M |
| March 31, 2018 | 1.115B |
| December 31, 2017 | 1.413B |
| Date | Value |
|---|---|
| September 30, 2017 | 1.774B |
| June 30, 2017 | 1.467B |
| March 31, 2017 | 1.149B |
| December 31, 2016 | 1.108B |
| September 30, 2016 | 799.59M |
| June 30, 2016 | 953.02M |
| March 31, 2016 | 680.45M |
| December 31, 2015 | 1.007B |
| September 30, 2015 | 1.116B |
| June 30, 2015 | 1.282B |
| March 31, 2015 | 1.360B |
| December 31, 2014 | 1.017B |
| September 30, 2014 | 975.97M |
| June 30, 2014 | 871.88M |
| March 31, 2014 | 977.43M |
| December 31, 2013 | 1.238B |
| September 30, 2013 | 1.252B |
| June 30, 2013 | 1.171B |
| March 31, 2013 | 1.148B |
| December 31, 2012 | 1.326B |
| September 30, 2012 | 1.328B |
| June 30, 2012 | 1.330B |
| March 31, 2012 | 1.207B |
| December 31, 2011 | 912.94M |
| September 30, 2011 | 775.51M |
Free Cash Flow Range, Past 5 Years
1.497B
Minimum
Jun 2019
3.888B
Maximum
Sep 2020
2.161B
Average
1.872B
Median
Jun 2021
Free Cash Flow Benchmarks
| Biodexa Pharmaceuticals Plc | -8.842M |
| NuCana PLC | -33.49M |
| TC BioPharm (Holdings) PLC | -13.42M |
| Bicycle Therapeutics PLC | -63.56M |
| Biophytis SA | -14.21M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 766.67M |
| Cash from Investing (Quarterly) | -101.71M |
| Cash from Financing (Quarterly) | -800.38M |
| Free Cash Flow Per Share (Quarterly) | 0.8493 |
| Free Cash Flow to Equity (Quarterly) | 780.68M |
| Free Cash Flow to Firm (Quarterly) | 566.54M |
| Free Cash Flow Yield | 16.98% |